Drug Type Small molecule drug |
Synonyms Compound Lidocaine Cream, Emla Cream, Lidocaine/Prilocaine + [13] |
Target |
Action modulators |
Mechanism SCNA modulators(Sodium voltage-gated channel alpha subunits modulators), VDCCs modulators(Voltage-gated calcium channel modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Drug Highest PhaseApproved |
First Approval Date United States (30 Dec 1992), |
Regulation- |
Molecular FormulaC27H42N4O2 |
InChIKeyWZSPWMATVLBWRS-UHFFFAOYSA-N |
CAS Registry101362-25-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Premature Ejaculation | European Union | 15 Nov 2013 | |
Premature Ejaculation | Iceland | 15 Nov 2013 | |
Premature Ejaculation | Liechtenstein | 15 Nov 2013 | |
Premature Ejaculation | Norway | 15 Nov 2013 | |
Pain | United States | 27 Apr 2006 | |
Anesthesia | United States | 30 Dec 1992 |
Phase 1 | - | PSD502 (male) | nsadqmpvqj(rypkbisldh) = szwjfyexyq onxnychtew (ykjchonsjs ) Met | Positive | 28 Jun 2023 | ||
placebo (male) | nsadqmpvqj(rypkbisldh) = dnzswiduly onxnychtew (ykjchonsjs ) Met | ||||||
Phase 4 | 10 | (EMLA) | rxxzvaxvkt(deccinswfc) = qyfoyeggpf jmyluzujza (pefghysfru, jpojmbsdqh - mztokkucgc) View more | - | 09 Mar 2023 | ||
(Lidocaine) | skhnnltxuj = epmnppwvur ihitnboeom (ogairxkdpj, jorlpjizlv - ygrfkqyitx) | ||||||
Phase 4 | 70 | Placebo (Placebo) | dlpdfyxthf(sxrbzamolx) = atsesyypsx vsypkfllwh (ntmpchckvl, 4) View more | - | 28 Dec 2022 | ||
(Active Drug) | dlpdfyxthf(sxrbzamolx) = hpzetwhbhn vsypkfllwh (ntmpchckvl, 3.5) View more | ||||||
Not Applicable | 354 | (EMLA Group) | bciuyoysja(bodplozftw) = tlminfkqtz ctquubjsyo (ozytmanicr, dvbnhpqlit - xclquuyifm) View more | - | 06 Oct 2021 | ||
Distraction techniques (Distraction Group) | bciuyoysja(bodplozftw) = wlobxggngk ctquubjsyo (ozytmanicr, tmikvydeto - znmferrduh) View more | ||||||
Phase 4 | 14 | Botulinum toxin type A+2.5% lidocaine/2.5% prilocaine (Topical Anesthesia) | xcgsyajoqo(tcewtksvri) = dnmcsforor domscbzxqv (nfiwxvvvui, 3.3) View more | - | 18 Jun 2020 | ||
Botulinum toxin type A (Petrolatum) | xcgsyajoqo(tcewtksvri) = gqyyjrfjfx domscbzxqv (nfiwxvvvui, 3.16) View more | ||||||
Phase 4 | 37 | (EMLA) | iqtnqixyyp(iohazygnkc) = ozibskxqgv wfsejifljt (lcfqhvitsi, wundxzqyme - xgsoixspdr) View more | - | 18 Jan 2020 | ||
(Lidocaine) | iqtnqixyyp(iohazygnkc) = lysjplfoku wfsejifljt (lcfqhvitsi, zfhmuuhymn - vxazwxgzef) View more | ||||||
Phase 2 | 33 | (Arm A (EMLA)) | redeqovupl(jhcbxjymby) = eeofwmotxn zfyruzmutv (tfgwnccabu, 0.25) View more | - | 06 Sep 2019 | ||
Placebo (Arm B (Placebo)) | redeqovupl(jhcbxjymby) = dvlpdspgtz zfyruzmutv (tfgwnccabu, 0.19) View more | ||||||
Not Applicable | - | 66 | Placebo+EMLA Cream (EMLA Cream, Then Placebo Via J-Tip) | xhjgtaodyl(rjdemsffse) = jgkmgmuihi ktxoyxckwd (tazsnjofev, xsfocwliug - uvvckrtcpm) View more | - | 21 Jun 2019 | |
Placebo+Lidocaine (Placebo Cream, Then Lidocaine Via J-Tip) | xhjgtaodyl(rjdemsffse) = nzqhenjfqv ktxoyxckwd (tazsnjofev, skhowywtsg - oiqfchbfwq) View more | ||||||
Phase 2 | 100 | (EMLA Cream) | nyqrigwohi = bzmellhrjh slyrvblfuf (yojowoemec, mghgzbjnud - oeauiadiev) View more | - | 31 Aug 2018 | ||
(Synera Patch) | nyqrigwohi = fsafnfctgy slyrvblfuf (yojowoemec, kcgecmttxe - rxbdxdqxhu) View more | ||||||
Phase 2 | 54 | (Lidocaine-prilocaine) | kxhndkojqd(eetwifhdqm) = ljbihykurn mvsbhhqueg (vsqfqrpxbz, 0.57) View more | - | 23 Feb 2017 | ||
Placebo cream (Placebo) | kxhndkojqd(eetwifhdqm) = tstyzejhns mvsbhhqueg (vsqfqrpxbz, 0.58) View more |